期刊
BLOOD
卷 112, 期 5, 页码 1655-1657出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2008-03-147785
关键词
-
类别
Cutaneous mastocytosis (CM) in children is a usually benign skin disorder caused by mast cell proliferation. Progressive disease leading to systemic involvement and fatal outcomes has been described. C-kit receptor mutations have been identified as causative for CM, some of which potentially respond to imatinib treatment as described for patients with systemic mastocytosis. We report successful therapy of progressive CM with imatinib in a 23-month-old boy. KITgene analysis revealed not only a somatic deletion of codon 419 in exon8(c.1255_1257delGAC) which responds to imatinib therapy, but also a novel germ line p.Ser840Asn substitution encoded by exon 18 in the c-kit kinase domain. Family history suggests this exchange does not affect receptor function or cause disease. Imatinib therapy was well tolerated, stopped symptoms and disease progression, and appeared to shorten the course of the disease. Imatinib could possibly represent a novel therapeutic option in patients with progressive CM.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据